World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 28 August 2023
Main ID:  NCT03422770
Date of registration: 18/01/2018
Prospective Registration: No
Primary sponsor: Norwegian University of Science and Technology
Public title: Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis
Scientific title: Ultrasonic Markers for Myocardial Fibrosis and Prognosis in Aortic Stenosis
Date of first enrolment: January 9, 2018
Target sample size: 132
Recruitment status: Completed
URL:  https://clinicaltrials.gov/ct2/show/NCT03422770
Study type:  Interventional
Study design:  Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Norway
Contacts
Name:     Brage Høyem Amundsen, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Norwegian University of Science and Technology
Name:     Svend Aakhus, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Norwegian University of Science and Technology
Key inclusion & exclusion criteria

Inclusion Criteria:

- Able to undergo protocolled investigations

- Patients: Mild, moderate or severe AS

Exclusion Criteria:

- Renal insufficiency

- Previously myocardial infarction (ECG, echocardiogram or hospital record)

- Severe valvular heart disease (except patients)

- Other cardiac disease known to cause myocardial fibrosis

- Severe hypertension

- Other medical conditions deterring protocolled investigation and follow-up

- Other medical conditions affecting 5-yrs prognosis (cancer, pulmonary disease)

- Severely reduced image-quality (echocardiography and MRI)



Age minimum: 18 Years
Age maximum: 90 Years
Gender: All
Health Condition(s) or Problem(s) studied
Aortic Valve Stenosis
Myocardial Fibrosis
Intervention(s)
Diagnostic Test: Blood test
Diagnostic Test: 6 min walking test
Diagnostic Test: ECG and Holter-ECG
Diagnostic Test: Echocardiography
Diagnostic Test: MRI
Primary Outcome(s)
Cardiovascular morbidity and mortality [Time Frame: 1 + 3 year]
Secondary Outcome(s)
Time of first re-hospitalisation [Time Frame: 3 years]
Cardiac diastolic function [Time Frame: 1 year.]
Cardiac systolic function [Time Frame: 1 year.]
All cause mortality [Time Frame: 3 years]
Secondary ID(s)
2017/1068
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Oslo University Hospital
St. Olavs Hospital
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history